We did not observe a statistical difference in IDO1, IDO2, TDO2, and IL4I1 expression between PD‐L1+ and PD‐L1− samples in NK/TCL (Figure 2B) or DLBCL (Figure 2C) using IHC analysis. The gene discussed is IL4I1; the disease is diffuse large B-cell lymphoma.